August 18, 2025

Qiagen N.V. (QGEN) Stock Analysis: Unlocking Potential with 6.16% Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector specializing in diagnostics and research, is drawing attention from investors with a potential upside of..

CVS Health Corporation (CVS): Investor Outlook Highlights a Promising 17.82% Upside Potential

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to a diversified healthcare model. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: A 251% Potential Upside Catches Investor Attention

For investors seeking promising opportunities in the healthcare sector, Vaxcyte, Inc. (NASDAQ: PCVX) offers a compelling case with a substantial potential upside. This biotechnology company, based..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a -28.75% Potential Downside with Strategic Insights

Oscar Health, Inc. (NYSE: OSCR) sits at a pivotal juncture in the healthcare sector, offering a unique blend of technology-driven insurance products. As a significant player..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 39.40% Potential Upside

For investors with a keen eye on the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents a compelling case, particularly with its notable 39.40% potential upside. Despite..

Regeneron Pharmaceuticals, Inc. (REGN): Investor Outlook Reveals 23.5% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology industry with a market capitalization of $61.52 billion, is capturing the attention of investors with..

Moderna, Inc. (MRNA) Stock Analysis: Potential 62.74% Upside Despite Challenges in Revenue Growth

Investors eyeing the biotechnology sector may find Moderna, Inc. (NASDAQ: MRNA) a compelling yet complex proposition. With a market capitalization of $10.9 billion, this Cambridge, Massachusetts-based..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating a Promising 15.41% Upside in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Waters Corporation (WAT): Investor Outlook Reveals a Strong 20.13% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, specializes in diagnostics and research. Based in the United States, this company boasts a market..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Discover a 27.4% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

Lantheus Holdings, Inc. (LNTH): Investor Outlook with a 67% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, is drawing significant attention from investors due to its robust diagnostic and therapeutic product..

Baxter International Inc. (BAX): Investor Outlook with a 21.41% Potential Upside

Baxter International Inc. (NYSE: BAX) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $12.42..

ADMA Biologics Inc (ADMA) Stock Analysis: 71% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is capturing investor attention with its substantial growth potential and strategic market positioning. With..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 32%

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector specializing in both specialty and generic drug manufacturing, is catching the eye of investors..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a Stable Course in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $8.23..

Verona Pharma plc (VRNA) Investor Outlook: Navigating a High-Stakes Biotech with a $8.95 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA) is captivating investor attention with its robust market capitalization of $8.95 billion in the biotech sector, a testament to its promising..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potential Amidst Challenging Metrics

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market..

Tempus AI, Inc. (TEM) Investor Outlook: Navigating a Biotech Powerhouse with 89.6% Revenue Growth

Tempus AI, Inc. (NASDAQ: TEM) has been capturing investor attention with its impressive strides in the healthcare technology sector. With a market capitalization of $12.82 billion,..

Danaher Corporation (DHR) Stock Analysis: A 16.6% Upside Potential Amidst Robust Analyst Consensus

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling opportunity with significant growth potential. With a market capitalization..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 104% Upside in Biotech Innovation

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its compelling growth prospects and analyst..

Search

Funds

August 18, 2025

Search

Funds

August 18, 2025

FTSE 100

Funds